26 results
8-K
EX-1.1
ESPR
Esperion Therapeutics Inc.
22 Jan 24
Esperion Announces Proposed Public Offering of Common Stock
6:10am
, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import
8-K
EX-1.1
ESPR
Esperion Therapeutics Inc.
7 Dec 21
Esperion Announces Proposed Public Offering
4:01pm
has been in compliance with all statutes, rules, or regulations applicable to the ownership, testing, development, manufacture, packaging, processing
8-K
EX-10.1
oixp22qj6d7o
26 Jun 19
Esperion and Oberland Capital Announce $200 Million Funding Agreement
5:18pm
424B5
6fmrpd0p3wk
16 Oct 14
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
wb3flw
16 Oct 14
Entry into a Material Definitive Agreement
12:00am
424B5
y1oduu8u25zmqgk2i5
14 Oct 14
Prospectus supplement for primary offering
12:00am